Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.

Kooijman S, Wang Y, Parlevliet ET, Boon MR, Edelschaap D, Snaterse G, Pijl H, Romijn JA, Rensen PC.

Diabetologia. 2015 Nov;58(11):2637-46. doi: 10.1007/s00125-015-3727-0. Epub 2015 Aug 9.

2.

Inhibition of the central melanocortin system decreases brown adipose tissue activity.

Kooijman S, Boon MR, Parlevliet ET, Geerling JJ, van de Pol V, Romijn JA, Havekes LM, Meurs I, Rensen PC.

J Lipid Res. 2014 Oct;55(10):2022-32. doi: 10.1194/jlr.M045989. Epub 2014 Jul 12.

3.

The brain modulates insulin sensitivity in multiple tissues.

Parlevliet ET, Coomans CP, Rensen PC, Romijn JA.

Front Horm Res. 2014;42:50-8. doi: 10.1159/000358314. Epub 2014 Apr 7. Review.

PMID:
24732924
4.

Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.

Wang Y, Parlevliet ET, Geerling JJ, van der Tuin SJ, Zhang H, Bieghs V, Jawad AH, Shiri-Sverdlov R, Bot I, de Jager SC, Havekes LM, Romijn JA, Willems van Dijk K, Rensen PC.

Br J Pharmacol. 2014 Feb;171(3):723-34. doi: 10.1111/bph.12490.

5.

Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies.

Geerling JJ, Boon MR, Kooijman S, Parlevliet ET, Havekes LM, Romijn JA, Meurs IM, Rensen PC.

J Lipid Res. 2014 Feb;55(2):180-9. doi: 10.1194/jlr.R045013. Epub 2013 Nov 27. Review.

6.

GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice.

Parlevliet ET, Wang Y, Geerling JJ, Schröder-Van der Elst JP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H, Rensen PC.

PLoS One. 2012;7(11):e49152. doi: 10.1371/journal.pone.0049152. Epub 2012 Nov 2.

7.

Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulin-sensitive mice.

Coomans CP, Geerling JJ, Guigas B, van den Hoek AM, Parlevliet ET, Ouwens DM, Pijl H, Voshol PJ, Rensen PC, Havekes LM, Romijn JA.

J Lipid Res. 2011 Sep;52(9):1712-22. doi: 10.1194/jlr.M015396. Epub 2011 Jun 23.

8.

Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.

de Leeuw van Weenen JE, Parlevliet ET, Schröder-van der Elst JP, van den Berg SA, Willems van Dijk K, Romijn JA, Pijl H.

Exp Diabetes Res. 2011;2011:928523. doi: 10.1155/2011/928523. Epub 2011 Apr 6.

9.

Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice.

de Leeuw van Weenen JE, Auvinen HE, Parlevliet ET, Coomans CP, Schröder-van der Elst JP, Meijer OC, Pijl H.

J Neuroendocrinol. 2011 Feb;23(2):158-67. doi: 10.1111/j.1365-2826.2010.02092.x.

PMID:
21062378
10.

GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.

Parlevliet ET, de Leeuw van Weenen JE, Romijn JA, Pijl H.

Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E318-24. doi: 10.1152/ajpendo.00191.2010. Epub 2010 Jun 8.

11.

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.

de Leeuw van Weenen JE, Parlevliet ET, Maechler P, Havekes LM, Romijn JA, Ouwens DM, Pijl H, Guigas B.

Biochem Pharmacol. 2010 Jun 15;79(12):1827-36. doi: 10.1016/j.bcp.2010.01.029. Epub 2010 Feb 4.

PMID:
20138024
12.

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.

Parlevliet ET, Schröder-van der Elst JP, Corssmit EP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H.

J Pharmacol Exp Ther. 2009 Jan;328(1):240-8. doi: 10.1124/jpet.108.144154. Epub 2008 Oct 10.

13.

Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.

Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP.

Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E142-7. Epub 2007 Oct 30.

14.

Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice.

Heijboer AC, van den Hoek AM, Parlevliet ET, Havekes LM, Romijn JA, Pijl H, Corssmit EP.

Diabetologia. 2006 Apr;49(4):732-8. Epub 2006 Feb 17.

PMID:
16485139

Supplemental Content

Loading ...
Support Center